These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3094548)

  • 1. [Bioavailability of a valproic acid preparation. The relative bioavailability of enteric-resistant valproic acid preparations in tablet form with simultaneously administered tetradeuterated valproic acid as the bioavailability reference].
    Hoffmann F; Jancik BC; von Unruh GE
    Arzneimittelforschung; 1986 Jul; 36(7):1118-22. PubMed ID: 3094548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions.
    Klotz U
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic study of sodium di-n-propylacetate (usual tablet and enteric coated tablet with delayed absorption) (author's transl)].
    van de Mortel I; franck G
    Acta Neurol Belg; 1976; 76(3):165-72. PubMed ID: 788439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
    Bano G; Gupta S; Gupta KL; Raina RK
    J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteers.
    Dutta S; Reed RC; Cavanaugh JH
    J Clin Pharmacol; 2004 Jul; 44(7):737-42. PubMed ID: 15199078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.
    Bialer M; Rubinstein A; Raz I; Abramsky O
    Eur J Clin Pharmacol; 1984; 27(4):501-3. PubMed ID: 6440792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of different valproic acid formulations.
    Franke G; Diletti E; Hoffmann C; Zschiesche M; Scheuch E; Siegmund W
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):653-7. PubMed ID: 8963482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enteric-coated valproic acid.
    Albright PS; Bruni J; Suria D
    Ther Drug Monit; 1984; 6(1):21-3. PubMed ID: 6424275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
    Paton DM
    Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of three antacids on the bioavailability of valproic acid.
    May CA; Garnett WR; Small RE; Pellock JM
    Clin Pharm; 1982; 1(3):244-7. PubMed ID: 6821035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Daily variations in serum concentration of di-n-propyl-acetate in enteric soluble form (convulex): a study on 30 volunteers (author's transl)].
    Egli M; Wad N; Graf HP
    Schweiz Rundsch Med Prax; 1978 Jun; 67(26):974-80. PubMed ID: 353779
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the enteral absorption of valproic acid (author's transl)].
    Oelkers W; Stoffels G; Schäfer H; Reith H
    Arzneimittelforschung; 1977; 27(5):1088-90. PubMed ID: 328020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose kinetics and bioavailability of sodium-hydrogen divalproate.
    Anderson P; Elwin CE
    Clin Neuropharmacol; 1985; 8(2):156-64. PubMed ID: 3924399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
    Zhang SH; Zhou YD; He HX
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilim chrono: a multidose, crossover comparison of two formulations of valproate in healthy volunteers.
    Roberts D; Easter D; O'Bryan-Tear G
    Biopharm Drug Dispos; 1996 Mar; 17(2):175-82. PubMed ID: 8907724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.